Recent News

• 06.12.2025 - ANI Pharmaceuticals Announces Presentation of New Preclinical Data
• 06.12.2025 - ANI Pharmaceuticals Announces Presentation of New Preclinical Data
• 06.04.2025 - 2025 Jefferies Global Healthcare Conference
• 06.04.2025 - 2025 Jefferies Global Healthcare Conference
• 05.27.2025 - ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
• 05.27.2025 - ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
• 05.22.2025 - ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares
• 05.22.2025 - ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares
• 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
• 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ

Recent Filings

• 06.04.2025 - 8-K Current report
• 06.04.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 06.04.2025 - EX-99.1 EX-99.1
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 8-K Current report